OAG 83-333 is cited as a foundational opinion that established the reasoning for considering certain drug labeling as misbranding under Kentucky law. This decision revisits the principles laid out in OAG 83-333 to see if they still apply given new considerations about the ultimate consumer's understanding.
OAG 83-333 was Cited by OAG 85-114
Our AG treatments are described and categorized by large language models (AI) and are partially reviewed by Coalition directors. Learn more from our blog.
Disclaimer:
The Sunshine Law Library is not exhaustive and may contain errors from source documents or the import process. Nothing on this website should be taken as legal advice. It is always best to consult with primary sources and appropriate counsel before taking any action.
The Sunshine Law Library is not exhaustive and may contain errors from source documents or the import process. Nothing on this website should be taken as legal advice. It is always best to consult with primary sources and appropriate counsel before taking any action.